This award funds the final stages of preclinical development for medical technologies or therapeutics targeting diseases related to FY26 PRMRP topics. It supports projects advancing proof-of-concept or prototypes toward regulatory filing or clinical practice translation, focusing on products benefiting military Service Members, Veterans, and their Families. Funding caps at $5.6M per award over a maximum of 4 years.
Open to any type of entity, subject to additional eligibility clarifications. No specific restrictions stated, implying broad eligibility within the United States.
